<p><b>Abbreviations:</b> TNBC: triple negative breast cancer; BC/OvCa: breast cancer, ovarian cancer; LCS: low clinical significance; PM: pathogenic mutation; PrPM: predictive PM; RP: risk conferring polymorphism; US: unknown significance; ms: maternal; fs: paternal. <b>*Criteria for mutation screening:</b> Details are described in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0038361#s2" target="_blank">Methods</a> section.</p
*<p>BCP = 75.9% of TNBC.</p><p>BCP, basal core phenotype; HT, hormonal therapy; MRM, modified radic...
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Triple-negative breast cancer (TNBC) is a subtype of aggressive breast cancer and characterized by a...
Background Breast cancer is the most common cancer in women. 12–15% of all tumors are triple-nega...
Triple-negative breast cancer (TN BC) is associated with a poor prognosis and defines a subgroup of ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Recently, BRCA1 germline mutations were found in a high proportion (14–34%) of patients with triple-...
Triple Negative Breast Cancer (TNBC) is a type of breast cancer absent of estrogen and progesterone ...
• Female breast cancer is estimated to be the most common type of cancer diagnosed in 2015, represen...
Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although ...
Background: BRCAness is defined as shared tumour characteristics between sporadic and BRCA-mutated c...
Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor,...
*<p>BCP = 75.9% of TNBC.</p><p>BCP, basal core phenotype; HT, hormonal therapy; MRM, modified radic...
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Triple-negative breast cancer (TNBC) is a subtype of aggressive breast cancer and characterized by a...
Background Breast cancer is the most common cancer in women. 12–15% of all tumors are triple-nega...
Triple-negative breast cancer (TN BC) is associated with a poor prognosis and defines a subgroup of ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive ...
Recently, BRCA1 germline mutations were found in a high proportion (14–34%) of patients with triple-...
Triple Negative Breast Cancer (TNBC) is a type of breast cancer absent of estrogen and progesterone ...
• Female breast cancer is estimated to be the most common type of cancer diagnosed in 2015, represen...
Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although ...
Background: BRCAness is defined as shared tumour characteristics between sporadic and BRCA-mutated c...
Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor,...
*<p>BCP = 75.9% of TNBC.</p><p>BCP, basal core phenotype; HT, hormonal therapy; MRM, modified radic...
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Triple-negative breast cancer (TNBC) is a subtype of aggressive breast cancer and characterized by a...